MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, FLGT made $71,138K in revenue. -$24,826K in net income. Net profit margin of -34.90%.

Income Overview

Revenue
$71,138K
Net Income
-$24,826K
Net Profit Margin
-34.90%
Unit: Thousand (K) dollars
Revenue Breakdown
    • Clinical Institutional Contracts
    • Clinical Insurance Contracts
    • Clinical Patient Contracts
Revenue Breakdown
    • Precision Diagnostics
    • Anatomic Pathology
    • Biopharma Services
    • Revenue From Contract With Custo...
Revenue Breakdown
    • US
    • Other Countries
    • CN

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
71,138 83,336 84,069 81,803
Cost of revenue
49,648 50,754 48,557 47,368
Gross profit
21,490 32,582 35,512 34,435
Research and development
14,176 14,170 13,860 13,480
Selling and marketing
12,221 10,978 11,642 12,286
General and administrative
27,684 41,646 23,335 26,392
Amortization of intangible assets
2,031 2,026 2,025 1,990
Total operating expenses
56,112 68,820 50,862 54,148
Operating loss
-34,622 -36,238 -15,350 -19,713
Interest income
8,651 6,936 7,874 8,091
Interest expense
17 16 28 17
Impairment gain
-0 -9,926
Other income (expense), net
10 44 -5 46
Total other income, net
8,644 6,964 7,841 -1,806
Loss before income taxes
-25,978 -29,274 -7,509 -21,519
(benefit from) provision for income taxes
-704 -5,624 -683 -2,263
Net loss from consolidated operations
-25,274 -23,650 -6,826 -19,256
Net loss attributable to noncontrolling interests
-448 -232 -218 -299
Net loss attributable to fulgent
-24,826 -23,418 -6,608 -18,957
Basic Average Shares
30,881,000 30,983,000 30,749,000 30,544,000
Diluted Average Shares
30,881,000 30,983,000 30,749,000 30,544,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to fulgent-$24,826K (-115.32%↓ Y/Y)Net lossattributable to...-$448K (-21.41%↓ Y/Y)Net loss fromconsolidated operations-$25,274K (-112.40%↓ Y/Y)(benefit from) provisionfor income taxes-$704K (-500.00%↓ Y/Y)Interest income$8,651K (7.89%↑ Y/Y)Clinical InstitutionalContracts$40,933K (-0.95%↓ Y/Y)Clinical InsuranceContracts$27,379K (-10.95%↓ Y/Y)Clinical PatientContracts$2,826K (102.58%↑ Y/Y)Other income(expense), net$10K (-85.29%↓ Y/Y)Loss before incometaxes-$25,978K (-121.60%↓ Y/Y)Total other income,net$8,644K (7.09%↑ Y/Y)Revenue$71,138K (-3.16%↓ Y/Y)Interest expense$17K (21.43%↑ Y/Y)Operating loss-$34,622K (-74.90%↓ Y/Y)Gross profit$21,490K (-24.19%↓ Y/Y)Cost of revenue$49,648K (10.04%↑ Y/Y)Total operatingexpenses$56,112K (16.56%↑ Y/Y)General andadministrative$27,684K (9.46%↑ Y/Y)Research and development$14,176K (14.37%↑ Y/Y)Selling and marketing$12,221K (44.37%↑ Y/Y)Amortization of intangibleassets$2,031K (2.06%↑ Y/Y)

Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics, Inc. (FLGT)